GalChimia, Oncostellae, and AMSLab participates in the research project Oncogalfarma, whose goal is to develop new complementary therapies for the treatment of oncological diseases. The research is centered in the fields of inhibitors of protein–protein interactions (PPI) and nuclear receptors. The project has been financed by the Government of Galicia and co-financed by the European Regional Development Fund through the subprogramme CONECTA PEME. The total funding granted is €189,943.59. Click here for more information
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Check our privacy policy here.